Related Experiment Video
Updated: Nov 30, 2025

Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
Sugammadex in end-stage renal disease: too early for a "free-pass"
Rohan Magoon1, Ramesh Kashav2, Jasvinder Kaur Kohli2
1Department of Cardiac Anaesthesia, Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) and Dr. Ram Manohar Lohia Hospital, Baba Kharak Singh Marg, New Delhi, India. rohanmagoon21@gmail.com.
No abstract available in PubMed .
Related Concept Videos
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

